FY2018 Earnings Estimate for Shire PLC (SHPG) Issued By SunTrust Banks
Shire PLC (NASDAQ:SHPG) – Equities research analysts at SunTrust Banks cut their FY2018 earnings per share estimates for shares of Shire PLC in a report released on Tuesday. SunTrust Banks analyst J. Boris now anticipates that the brokerage will post earnings per share of $18.74 for the year, down from their prior estimate of $18.78. SunTrust Banks also issued estimates for Shire PLC’s FY2019 earnings at $23.72 EPS.
Shire PLC (NASDAQ:SHPG) last announced its earnings results on Tuesday, August 2nd. The biopharmaceutical company reported $3.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.03 by $0.35. The company earned $2.43 million during the quarter, compared to analysts’ expectations of $2.28 billion. Shire PLC had a net margin of 13.19% and a return on equity of 17.70%. The firm’s quarterly revenue was up 55.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.63 earnings per share.
SHPG has been the subject of several other research reports. HSBC lowered shares of Shire PLC from a “buy” rating to a “hold” rating in a research report on Monday, September 26th. Shore Capital restated a “buy” rating on shares of Shire PLC in a research report on Tuesday, August 30th. Citigroup Inc. restated a “buy” rating on shares of Shire PLC in a research report on Tuesday, September 27th. Zacks Investment Research upgraded shares of Shire PLC from a “hold” rating to a “buy” rating and set a $208.00 price target for the company in a research report on Tuesday, July 5th. Finally, Jefferies Group restated a “buy” rating and set a $262.00 price target on shares of Shire PLC in a research report on Tuesday, September 20th. Five research analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $232.75.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/07/fy2018-earnings-estimate-for-shire-plc-shpg-issued-by-suntrust-banks.html
Shares of Shire PLC (NASDAQ:SHPG) traded up 0.21% during trading on Friday, reaching $193.95. 466,580 shares of the company’s stock were exchanged. The firm has a market capitalization of $57.77 billion, a PE ratio of 40.31 and a beta of 1.16. Shire PLC has a 52 week low of $147.60 and a 52 week high of $231.32. The company’s 50-day moving average price is $195.68 and its 200 day moving average price is $186.83.
A number of institutional investors have recently added to or reduced their stakes in the company. Norges Bank purchased a new position in Shire PLC during the fourth quarter worth approximately $31,671,000. Ngam Advisors L.P. increased its position in Shire PLC by 22.8% in the first quarter. Ngam Advisors L.P. now owns 34,151 shares of the biopharmaceutical company’s stock worth $5,870,000 after buying an additional 6,333 shares in the last quarter. BlackRock Fund Advisors increased its position in Shire PLC by 10.0% in the first quarter. BlackRock Fund Advisors now owns 591,458 shares of the biopharmaceutical company’s stock worth $101,672,000 after buying an additional 53,889 shares in the last quarter. BlackRock Institutional Trust Company N.A. increased its position in Shire PLC by 11.2% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 5,009 shares of the biopharmaceutical company’s stock worth $861,000 after buying an additional 506 shares in the last quarter. Finally, NN Investment Partners Holdings N.V. purchased a new position in Shire PLC during the first quarter worth approximately $1,014,000. Hedge funds and other institutional investors own 24.26% of the company’s stock.
The business also recently declared a dividend, which will be paid on Friday, October 7th. Stockholders of record on Friday, September 9th will be given a $0.139 dividend. The ex-dividend date is Wednesday, September 7th. Shire PLC’s dividend payout ratio (DPR) is 15.63%.
About Shire PLC
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.